GINGER CARMICHAEL: Open Payments
NPI 1760974018 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 7 payments from 4 companies in 2025. Trend: 2023 $139 · 2024 $410 · 2025 $429
Education: $366Food & beverage: $63
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $366 |
| Incyte Corporation | 1 | $24 |
| ARRAY BIOPHARMA INC | 1 | $23 |
| Exelixis Inc. | 1 | $16 |
Products named: MONJUVI, LORBRENA, CABOMETYX.
Industry payments across CA — which companies pay providers there.
